Remix Therapeutics seals $60M funding for game-changing medical breakthroughs.
Key Points: Remix Therapeutics raised $60 million in funding to support the clinical development of its lead program, REM-422, and further advancement of its pipeline of RNA processing targeted therapeutics. The funding